• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Non-alcoholic steatohepatitis or metabolic-associated fatty liver: time to change.

作者信息

Shiha Gamal, Mousa Nasser

机构信息

Egyptian Liver Research Institute and Hospital (ELRIAH), Mansoura, Egypt.

Hepatology and Gastroenterology Unit, Internal Medicine Departmen, Faculty of Medicine, Mansoura University, Mansoura, Egypt.

出版信息

Hepatobiliary Surg Nutr. 2021 Jan;10(1):123-125. doi: 10.21037/hbsn-20-438.

DOI:10.21037/hbsn-20-438
PMID:33575301
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7867717/
Abstract
摘要

相似文献

1
Non-alcoholic steatohepatitis or metabolic-associated fatty liver: time to change.非酒精性脂肪性肝炎或代谢相关脂肪性肝病：是时候做出改变了。
Hepatobiliary Surg Nutr. 2021 Jan;10(1):123-125. doi: 10.21037/hbsn-20-438.
2
CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis.CD36 的棕榈酰化作用破坏游离脂肪酸代谢并促进非酒精性脂肪性肝炎中的组织炎症。
J Hepatol. 2018 Sep;69(3):705-717. doi: 10.1016/j.jhep.2018.04.006. Epub 2018 Apr 27.
3
Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study.非酒精性脂肪性肝炎患者血浆转化生长因子-β1水平及α-生育酚的疗效：一项初步研究
Aliment Pharmacol Ther. 2001 Oct;15(10):1667-72. doi: 10.1046/j.1365-2036.2001.01083.x.
4
Metabolic factors affecting hepatocellular carcinoma in steatohepatitis.影响脂肪性肝炎中肝细胞癌的代谢因素。
Liver Int. 2019 Mar;39(3):531-539. doi: 10.1111/liv.14002. Epub 2018 Dec 2.
5
Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis.代谢综合征与慢性病毒性肝炎和非酒精性脂肪性肝炎中的严重肝纤维化相关。
Aliment Pharmacol Ther. 2008 Jan 1;27(1):80-9. doi: 10.1111/j.1365-2036.2007.03538.x. Epub 2007 Oct 5.
6
A non-invasive prediction model for non-alcoholic steatohepatitis in paediatric patients with non-alcoholic fatty liver disease.非酒精性脂肪性肝病患儿非酒精性脂肪性肝炎的无创预测模型
Dig Liver Dis. 2014 Nov;46(11):1008-13. doi: 10.1016/j.dld.2014.07.016. Epub 2014 Aug 6.
7
PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis.聚腺苷二磷酸核糖聚合酶抑制剂可预防酒精性和非酒精性脂肪性肝炎。
J Hepatol. 2017 Mar;66(3):589-600. doi: 10.1016/j.jhep.2016.10.023. Epub 2016 Oct 29.
8
Diagnosis and classification of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Current concepts and remaining challenges.非酒精性脂肪性肝病和非酒精性脂肪性肝炎的诊断与分类：当前概念与尚存挑战
Hepatol Res. 2015 Jan;45(1):20-8. doi: 10.1111/hepr.12333. Epub 2014 May 20.
9
Non-alcoholic steatohepatitis and metabolic syndrome.非酒精性脂肪性肝炎与代谢综合征
Curr Opin Clin Nutr Metab Care. 2006 Sep;9(5):637-42. doi: 10.1097/01.mco.0000241677.40170.17.
10
[Non-alcoholic fatty liver disease and steatohepatitis].[非酒精性脂肪性肝病和脂肪性肝炎]
Orv Hetil. 2013 Jul 21;154(29):1124-34. doi: 10.1556/OH.2013.29626.

引用本文的文献

1
Macrophage metabolism in nonalcoholic fatty liver disease.非酒精性脂肪性肝病中的巨噬细胞代谢。
Front Immunol. 2023 Oct 4;14:1257596. doi: 10.3389/fimmu.2023.1257596. eCollection 2023.
2
Effects of PCSK9 inhibitors on metabolic-associated fatty liver disease: a short review.前蛋白转化酶枯草溶菌素9抑制剂对代谢相关脂肪性肝病的影响：简短综述
Prz Gastroenterol. 2023;18(2):148-153. doi: 10.5114/pg.2023.126054. Epub 2023 Mar 23.
3
Artificial Intelligence in NAFLD: Will Liver Biopsy Still Be Necessary in the Future?非酒精性脂肪性肝病中的人工智能：未来肝脏活检是否仍有必要？
Healthcare (Basel). 2022 Dec 30;11(1):117. doi: 10.3390/healthcare11010117.

本文引用的文献

1
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease.MAFLD：代谢相关脂肪性肝病的共识驱动命名建议。
Gastroenterology. 2020 May;158(7):1999-2014.e1. doi: 10.1053/j.gastro.2019.11.312. Epub 2020 Feb 8.
2
Nonalcoholic Steatohepatitis Is Associated With Liver-Related Outcomes and All-Cause Mortality in Chronic Hepatitis B.非酒精性脂肪性肝炎与慢性乙型肝炎的肝相关结局和全因死亡率相关。
Hepatology. 2020 Feb;71(2):539-548. doi: 10.1002/hep.30857. Epub 2019 Oct 17.
3
Is it time to change NAFLD and NASH nomenclature?是时候改变非酒精性脂肪性肝病（NAFLD）和非酒精性脂肪性肝炎（NASH）的命名法了吗？
Lancet Gastroenterol Hepatol. 2017 Aug;2(8):547-548. doi: 10.1016/S2468-1253(17)30146-2.
4
Histology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in Adults and Children.成人及儿童非酒精性脂肪性肝病和非酒精性脂肪性肝炎的组织学
Clin Liver Dis. 2016 May;20(2):293-312. doi: 10.1016/j.cld.2015.10.011. Epub 2015 Dec 28.
5
Concurrence of histologic features of steatohepatitis with other forms of chronic liver disease.脂肪性肝炎的组织学特征与其他形式慢性肝病的并存。
Mod Pathol. 2003 Jan;16(1):49-56. doi: 10.1097/01.MP.0000042420.21088.C7.